DAPA-HFrEF (Completed)
An International, Multicenter, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients with Chronic HFrEF
- Medicine
- dapagliflozin
- Population
- Heart failure
- Phase
- III
- Starting year
- 2016